Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
77 Cards in this Set
- Front
- Back
-Stable concentration in plasma
-freely filtered at the glomerulus -not reabsorbed, secreted, synthesized or metabolized by the kidney -can be easily measured using calorimetric assays |
Characteristics of an ideal marker for renal clearance
|
|
the amount filtered at the glomerulus...
|
is equal to the amount excreted in urine
|
|
-gold standard test for assessment of GFR
-an artificial carbohydrate that must be infused |
Inulin clearance
|
|
Inulin is a ______________ not normally present in the body
|
fructo-polysaccharide
|
|
Inulin clearance is considered impractical b/c?
|
the infusion must progress for an extended period of time to establish a constant plasma level
|
|
Inulin clearance is the gold standard becuase
|
what goes in, goes out
|
|
the most commonly used solute to calculate GFR in the lab
|
creatinine
|
|
creatinine clearance is overestimated by
|
10%
|
|
97-137 ml/min/1.73 m^2
|
creatinine clearance reference range for males
|
|
88-128 ml/min/1.73m^2
|
creatinine clearance reference range for females
|
|
by the time you see low creatinine clearance...
|
there is already a substantial amount of renal damage
|
|
were more concerned about low clearance than high clearance b/c
|
it is a sign of renal disease
|
|
Decreses with:
- decreased RPF -clogged basement membrance -chronic renal disease -age |
GFR or CrCl
|
|
-does not require timed urine collection
-helpful in early detection of chronic kidney disease |
Esitmated GFR (eGFR)
|
|
Used to monitor and assess renal function
|
NPN compounds
|
|
Arise from the breakdown of proteins and nucleic acids and include:
-urea -creatinine -creatine -uric acid -ammonia -amino acids |
NPN compounds
|
|
Is not a marker for renal disease, but can give an idea of how GFR is going. IS a marker for liver disease
|
ammonia
|
|
elevated level of NPN compounds in blood
|
Azotemia
|
|
-Major excretory product of urine metabolism
-Synthesized in liver from CO2 and ammonia arising from deamination of amino acids |
Urea
|
|
-Freely filtered (MW=60D), 40-60% is reabsorbed and the rest is excreted by kidneys
|
Urea
|
|
Serum urea is reported as...
|
BUN (blood urea-nitrogen)
|
|
measurement of urea alone _____ a useful indicator of renal function
|
urea
|
|
-small amounts also secreted through GI tract and skin
|
Urea
|
|
the first thing to increase in dehydration
|
Urea
|
|
In analytical methods of urea the first step involves
|
the hydrolysis of urea by urease and production of NH4
|
|
the second steps in analytical methods of urea can involve
|
quantitaion of ammonium ion by enzymatic method
|
|
Interference in anlytical methods of urea include? (2)
|
-citrate and flouride( inhibit urease)
-increased ammonium ion concentration |
|
6-20 mg/dL ; 10:1 to 20:1
|
BUN reference range in Urea analytical methods
|
|
What two tube tops do we not use in Urea analytical method?
|
no blue top or grey top
|
|
very high plasma urea concentration accompanied by renal failure
|
uremia
|
|
Decreased renal blood flow (CHF, dehydration)
|
prerenal azotemia
|
|
Intrinsic renal faliure (acute or chronic)-->decreased renal function
|
renal azotemia
|
|
obstruction in the urinary system(causes very high creatinine)
|
post renal azotemia
|
|
seen in:
-decreased protien intake -liver disease -severe diarrhea and vomitting -pregnancy |
decreased urea concentration
|
|
synthesized in liver from the breakdown of nucleic acids (DNA and RNA) and transported to the kidney
|
uric acid
|
|
Most is reabsorbed, rest is excreted by kidneys (most) and GI tract
|
Uric acid
|
|
present in plasma and monosodium urate
|
Uric acid
|
|
At >6.4 mg/dL, plasma is saturated with
|
urate crystals and may also precipitate in the tissues
|
|
3.5-7.2 mg/dLmale
2.6-6.0 mg/dLfemale |
Uric acid reference range
|
|
-uric acid is oxidized to allantoin(water soluble product) and phosphotungstic acid is reduced to tungsten blue
-sodium carbonate provides the alkaline medium necessary for color development |
Phosphotungstic method for uric acid
|
|
uric acid is oxidized to allantoin by the enzyme uricase and differential absorbance is measured
|
Uricase method for Uric acid
|
|
In analytical methods for uric acid, samples must be
|
either serum, plasma, or urine
|
|
-caused by overproduction or underexcretion of uric acid
-increased catabolism of nucleic acid,purine rich diet=overproduction of uric acid -renal disease= under excretion |
hyperuricemia
|
|
Uncommon, secondary to other conditions
|
hypouricemia
|
|
occurs when uric acid is so elecated (>6 mg/dL) it precipitates our of solution in plasma
|
Gout
|
|
caused by overproduction of uric acid, purine rich diet, drugs or alcohol
|
Gout
|
|
occurs primarily between 30-50 years of age
|
Gout
|
|
-MSU crystals deposit in joints and soft tissue causing pain and inflammation.
-In sever cases, deposits of urates called tophi form in tissues surrounding the joints, causing deformities |
Gouty arthritis
|
|
-may be accompanied by uric acid stones in urinary tract
-to fix crsytals the pH of the body must be adjusted |
Gout
|
|
Formed in the GI tract by the deamination of amino acids
|
Ammonia
|
|
-normally metabolized by the liver to produce urea
- At physiologic pH, exists in the blood as NH4 |
ammonia
|
|
Increase in plasma oH shifts the ammonia equilibrium to the right, resulting in
|
increased NH3 concentration
|
|
Increased blood ammonia levels
|
hyperammonia
|
|
Seen in:
-sever liver disease- not metabolized -reye's syndrome -renal disease -inherited deficiency of the urea cycle enzymes |
Hyperammonemia
|
|
Two analytical methods for ammonia
|
-coupled enzymatic method
-ammonia ISE method |
|
-whole blood or plasma- immeadiately on ice and centrifuged in refrigerated centrifuge
-anticoagulants-EDTA or heparin -centrifuge samples at refrigerated temperature and assay ASAP(w/in 20 mins) |
samples for analytic methods of ammonia
|
|
sources of error in analytic methods of ammonia
|
-hemolysis
-cigarette smoking by the patient -ammonia in detergerents, reagents, water and glassware -drugs |
|
low molecular weight cysteine protease inhibitor protein produced by all nucleated cells
|
Cystatin C
|
|
-freely filtered by glomerulus, reabsorbed and catabolized (rapidly) byt PCT
-produced and removed at a constant rate |
Cystatin C
|
|
-Increased levels in serum indicates impaired renal function
|
Cystatin C
|
|
-rise can be measurable before increase in creatinine or decrease in GFR
-correlates with decreased GFR -does not depend on age, muscle mass, etc. |
Increases serum Cystatin C
|
|
Tests:
-creatinine - BUN -Creatinine Clearance -Total protein -uric acid -cystatin C -osmolality -electrolytes |
Commonly used kidney function test
|
|
-sudden sharp decline in renal function as a result of acute toxic or hypoxic insult to the kidneys
-GFR is reduced to <10 ml/min. |
Acute Renal Failure
|
|
-gradual decline in renal function over time
-occurs in five stages |
Chronic renal failure or kidney disease
|
|
Stage:
-kidney damage with normal or not equal GFR -GFR >90 mL/min/1.73m^2 |
stage one of chronic kidney disease stages
|
|
-kidney damage with normal or decreased GFR
-GFR= 60-89 mL/min./1.73m^2 |
Stage two of chronic kidney disease stage
|
|
-kidney damage with moderate decreased GFR
-GFR=30-59 mL/min/1.73m^2 |
stage three of chronic kidney disease
|
|
-kidney damage with severely decreased GFR
- GFR=15-29 mL/min/1.73m^2 |
Stage four of chronic kidney disease
|
|
-kidney failure
-GFR= <15mL/min/1.73m^2 |
Stage final of chronic kidney disease
|
|
-failure of kidneys to maintain its basic functions
-caused by a variety of intrinsic renal problems like hypertension, lupus or nephrotoxicity |
End stage renal disease
|
|
Symptoms:
-weakness, tremors, loss of appetite, metabolic axidosis Lab findings: -Increased BUN and serum creatinine -Decreased GFR(~5 mL/min) -Increased serum phosphorus and potassium -decreased serum calcium -Increased BP |
End stage renal disease
|
|
-injury to glomerular tissue by immune complexes formed with bete hemolytic strep.
-Lab findings: hematuria, proteinuria, reduced GFR, increased sodium, and hypertension |
Acute glomerulonephritis
|
|
-loss of nephron mass over a prolonged period of time
-Lab findings: same as acute, except slight hematuria and proteinuria |
Chronic glomerulonephritis
|
|
-Increased permeability of the glomerular basement membrane induced by disorders like diabetes mellitus, lupus,etc.
|
Nephrotic syndrome
|
|
Lab findings:
-hyperproteinemia, hypoproteinemia,(hypoalbuminemia), azotemia, hyperlipidemia, lipiduria -Symptoms: edema |
Nephrotic syndrome
|
|
-Acute and non- infectious pyelonephritis
|
tubular disease
|
|
-decreased excretion/reabsorption of certain substances or reduced urinary concentrating ability (caused by drug toxicity, GNB, etc.)
-Lab findings: decreased GFR, acidosis (decreased H+ secretion) |
Tubular disease
|